These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 20703861

  • 1. Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer.
    Usuda K, Sagawa M, Aikawa H, Ueno M, Tanaka M, Machida Y, Zhao XT, Ueda Y, Higashi K, Sakuma T.
    Gen Thorac Cardiovasc Surg; 2010 Aug; 58(8):405-10. PubMed ID: 20703861
    [Abstract] [Full Text] [Related]

  • 2. ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
    Hong R, Lim SC.
    World J Gastroenterol; 2012 Jan 14; 18(2):168-74. PubMed ID: 22253523
    [Abstract] [Full Text] [Related]

  • 3. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
    Furukawa T, Miyata Y, Kushitani K, Mimae T, Tsutani Y, Takeshima Y, Okada M.
    Jpn J Clin Oncol; 2015 Dec 14; 45(12):1154-61. PubMed ID: 26386467
    [Abstract] [Full Text] [Related]

  • 4. Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
    Taylor MD, Smith PW, Brix WK, Wick MR, Theodosakis N, Swenson BR, Kozower BD, Lau CL, Jones DR.
    J Thorac Cardiovasc Surg; 2009 Jan 14; 137(1):43-8. PubMed ID: 19154901
    [Abstract] [Full Text] [Related]

  • 5. Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.
    Schuurbiers OC, Meijer TW, Kaanders JH, Looijen-Salamon MG, de Geus-Oei LF, van der Drift MA, van der Heijden EH, Oyen WJ, Visser EP, Span PN, Bussink J.
    J Thorac Oncol; 2014 Oct 14; 9(10):1485-93. PubMed ID: 25170642
    [Abstract] [Full Text] [Related]

  • 6. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
    Duan Y, Yu LJ, Lu PO, Wang WZ.
    Zhonghua Zhong Liu Za Zhi; 2008 Oct 14; 30(10):764-7. PubMed ID: 19173807
    [Abstract] [Full Text] [Related]

  • 7. [Relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung adenocarcinoma].
    Wang T, Sun YE, Yao SL, Tian JH, Liu XB, Wang K.
    Zhonghua Wai Ke Za Zhi; 2004 Aug 22; 42(16):968-71. PubMed ID: 15363231
    [Abstract] [Full Text] [Related]

  • 8. Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
    Kasahara N, Kaira K, Bao P, Higuchi T, Arisaka Y, Erkhem-Ochir B, Sunaga N, Ohtaki Y, Yajima T, Kosaka T, Oyama T, Yokobori T, Asao T, Nishiyama M, Tsushima Y, Kuwano H, Shimizu K, Mogi A.
    Lung Cancer; 2018 May 22; 119():71-77. PubMed ID: 29656756
    [Abstract] [Full Text] [Related]

  • 9. Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung.
    Tsutani Y, Miyata Y, Misumi K, Ikeda T, Mimura T, Hihara J, Okada M.
    Jpn J Clin Oncol; 2011 Jul 22; 41(7):890-6. PubMed ID: 21613306
    [Abstract] [Full Text] [Related]

  • 10. GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome.
    Meziou S, Ringuette Goulet C, Hovington H, Lefebvre V, Lavallée É, Bergeron M, Brisson H, Champagne A, Neveu B, Lacombe D, Beauregard JM, Buteau FA, Riopel J, Pouliot F.
    Prostate Cancer Prostatic Dis; 2020 Sep 22; 23(3):441-448. PubMed ID: 31932660
    [Abstract] [Full Text] [Related]

  • 11. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
    Nakamura H, Hirata T, Kitamura H, Nishikawa J.
    Ann Thorac Cardiovasc Surg; 2009 Oct 22; 15(5):304-10. PubMed ID: 19901884
    [Abstract] [Full Text] [Related]

  • 12. The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma.
    Kokeza J, Strikic A, Ogorevc M, Kelam N, Vukoja M, Dilber I, Zekic Tomas S.
    Int J Mol Sci; 2023 Jun 24; 24(13):. PubMed ID: 37445752
    [Abstract] [Full Text] [Related]

  • 13. Correlation of Glut-1 glucose transporter expression with.
    Higashi K, Ueda Y, Sakurai A, Wang XM, Xu L, Murakami M, Seki H, Oguchi M, Taki S, Nambu Y, Tonami H, Katsuda S, Yamamoto I.
    Eur J Nucl Med; 2000 Dec 24; 27(12):1778-85. PubMed ID: 11189940
    [Abstract] [Full Text] [Related]

  • 14. [Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma].
    Wang T, Sun YE, Tian JH, Liu XB, Yao SL, Wang K.
    Zhonghua Wai Ke Za Zhi; 2003 Dec 24; 41(12):913-6. PubMed ID: 14728832
    [Abstract] [Full Text] [Related]

  • 15. [18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules.
    de Koster EJ, van Engen-van Grunsven ACH, Bussink J, Frielink C, de Geus-Oei LF, Kusters B, Peters H, Oyen WJG, Vriens D, EFFECTS trial study group.
    Mol Imaging Biol; 2023 Jun 24; 25(3):483-494. PubMed ID: 36253663
    [Abstract] [Full Text] [Related]

  • 16. Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
    Grabellus F, Nagarajah J, Bockisch A, Schmid KW, Sheu SY.
    Clin Nucl Med; 2012 Feb 24; 37(2):121-7. PubMed ID: 22228332
    [Abstract] [Full Text] [Related]

  • 17. Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma.
    Xia H, Chen J, Gao H, Kong SN, Deivasigamani A, Shi M, Xie T, Hui KM.
    Eur J Nucl Med Mol Imaging; 2020 Apr 24; 47(4):787-797. PubMed ID: 31832727
    [Abstract] [Full Text] [Related]

  • 18. Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma.
    Kaira K, Endo M, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Tsuya A, Nakamura Y, Naito T, Hayashi I, Kondo H, Nakajima T, Yamamoto N.
    Lung Cancer; 2011 Feb 24; 71(2):144-50. PubMed ID: 20646779
    [Abstract] [Full Text] [Related]

  • 19. Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
    Zhou X, Chen R, Xie W, Ni Y, Liu J, Huang G.
    J Nucl Med; 2014 Nov 24; 55(11):1766-71. PubMed ID: 25342384
    [Abstract] [Full Text] [Related]

  • 20. The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
    Kim SJ, Hwang SH, Kim IJ, Lee MK, Lee CH, Lee SY, Lee EY.
    J Exp Clin Cancer Res; 2010 Jun 12; 29(1):69. PubMed ID: 20540786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.